Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1836446

Cl.O=C(c1ccc(F)cc1F)C1CCNCC1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E known ✓ A5X5Y0 1/20 0.46
HTR3B known ✓ O95264 1/20 0.46
HTR3A known ✓ P46098 1/20 0.46
HTR3D known ✓ Q70Z44 1/20 0.46
HTR3C known ✓ Q8WXA8 1/20 0.46
HSD11B1 known ✓ P28845 1/20 0.40
HRH3 known ✓ Q9Y5N1 1/20 0.40
GAA known ✓ P10253 1/20 0.39
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
CYP2D6 P10635 1/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
NPY2R P49146 1/20 0.46
CPS1 P31327 1/20 0.43
ACKR3 P25106 1/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672830 0.98 CES2 (0.52) CES2CES1L3MBTL1MEN1KMT2A
Fumaric Acid SCHEMBL10637939 0.90 SLC6A2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
Fumaric Acid SCHEMBL10637950 0.90 SLC6A2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
SCHEMBL6141006 0.88 L3MBTL1 (0.61) CES2CES1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL31196625 0.87 CES2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL15567881 0.87 CES2 (0.50) CES2CES1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL10964891 0.86 MEN1 (0.46) CES2CES1L3MBTL1MEN1KMT2A
SCHEMBL30323082 0.85 CES2 (0.52) CES2CES1L3MBTL1MEN1KMT2A
SCHEMBL20524724 0.85 CES2 (0.52) CES2CES1L3MBTL1MEN1KMT2A
Hydrochloric Acid SCHEMBL11617261 0.84 MEN1 (0.60) MEN1KMT2ACYP2D6HTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119552159-A Preparation method of paliperidone 泰山学院 2025-03-04 CN claimed
CN-118641654-B Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-12-17 CN claimed
CN-118641654-A Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-09-13 CN claimed
CN-111393425-B Preparation method of 6-fluoro-3-piperidine-4-yl-1, 2-benzisoxazole hydrochloride 浙江京新药业股份有限公司 2021-11-26 CN claimed
CN-111777601-B Preparation method of 6-fluoro-3- (4-piperidyl) -1, 2 benzisoxazole hydrochloride 白银京宇新药业有限公司 2021-07-16 CN claimed
CN-111777601-A Preparation method of 6-fluoro-3- (4-piperidyl) -1, 2 benzisoxazole hydrochloride 白银京宇新药业有限公司 2020-10-16 CN claimed
CN-111393425-A Preparation method of 6-fluoro-3-piperidine-4-yl-1, 2-benzisoxazole hydrochloride 浙江京新药业股份有限公司 2020-07-10 CN claimed
CN-121692955-A Perovskite solar cell based on fluorine-containing piperidine hydrochloride modified buried bottom interface and preparation method thereof 海南大学 2026-03-17 CN disclosed
CN-119552159-A Preparation method of paliperidone 泰山学院 2025-03-04 CN disclosed
CN-118641654-B Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-12-17 CN disclosed
CN-118641654-B Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-12-17 CN disclosed
CN-118641654-B Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-12-17 CN disclosed
CN-118641654-A Method for detecting related substances of 4- (2, 4-difluorobenzoyl) -piperidine hydrochloride serving as initial raw material of paliperidone 山东泰合医药科技有限公司 2024-09-13 CN disclosed
WO-1996035713-A1 DIPEPTIDES WHICH PROMOTE RELEASE OF GROWTH HORMONE PFIZER, INC. (US) 1996-11-14 WO disclosed
EP-0686632-A1 BENZOTHIAZINE DERIVATIVE SUNTORY LIMITED (JP) 1995-12-13 EP disclosed
EP-0557289-A1 4-(1,2-BENZISOXAZOLYL)PIPERIDINE ANTIPSYCHOTIC AGENTS. PFIZER (US) 1993-09-01 EP disclosed
EP-0196132-B1 1,2-BENZISOXAZOL-3-YL AND 1,2-BENZISOTHIAZOL-3-YL DERIVATIVES JANSSEN PHARMACEUTICA N.V. (BE) 1992-08-12 EP disclosed
WO-1992008718-A1 4-(1,2-BENZISOXAZOLYL)PIPERIDINE ANTIPSYCHOTIC AGENTS PFIZER INC. (US) 1992-05-29 WO disclosed
US-4804663-A PSYCHOLOGICAL DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 1989-02-14 US disclosed
EP-0196132-A2 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1986-10-01 EP disclosed